However, LCN2 has also been shown to act as an anti-inflammatory mediator in other CNS diseases, such as experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS) [15], and LPS-induced stimulation of bone marrow–derived macrophages [16]. This evidence concerns the gene LCN2 and multiple sclerosis.